The purpose of research is to uncover truths, that is to describe reality validly. But all truths are not equally generalizable, and all research is not equally justifiable. For example, the value of a study that requires an N of 100,000 to reach statistical significance (a presumed truth) is likely to be far less than that of a study requiring only an N of 10. Furthermore, the value of research is related to the relevance of the finding to the ‘great issues’. In the field of health, the two great issues are function and feeling – the capacity to act and the quality of life. Investigators, universities, mentors, and funding sources need to consider truthfully whether a proposed research project is directed towards uncovering a relevant truth, one that has a reasonable chance of improving function and/or feeling, or leading to findings that will improve function or feeling. The development of a useless or harmful product, the publication of an irrelevant paper, the support of a ‘brilliant investigator’, and the development of a prestigious department are not adequate justifications for performing research. The consequences of the present system – driven by financial gain, power, and prestige – are exemplified in the comparison of the large amount of funds being expended to improve cataract surgery (which is already an incredibly successful procedure), yet at the same time almost no funds are being spent to study how to detect people with glaucoma who will go blind, fully 1% of the world’s population.

Keywords:
Social responsibility, Statistical significance, Funding, Research purpose, Priorities, Validity, Relevance, New ideas
1.
Wheeler-Schilling TH, Kremer J, Zrenner E: A Vision for Horizon 2020: A European Strategic Roadmap for Vision Research and Ophthalmology. Aechen, Shaker, 2012.
2.
Spaeth GL: Valid relevance in medical practice: the Inadequacy of the linear model of health and disease – the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2011;52:6250–6256.
4.
Harry G: On Bullshit. Frankfurt, Princeton University Press, 2005.
5.
Coleman D: Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers. Acad Med 2008;83:882–887.
6.
Angell M: Industry-sponsored clinical research: a broken system. JAMA 2008;300:1069–1071.
7.
Angell M: Relationships with the drug industry: keep at arm’s length. BMJ 2009;338:b222.
8.
Coleman D, Kazdin A, Miller L, Morrow J, Udelsman R: Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school’s approach. Acad Med 2006;81:154–160.
9.
Kass MA, Heuer DK, Higginbotham EJ, et al: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–713.
10.
Klausen J: The Cartoons that Shook the World. New Haven, Yale University Press, 2002.
11.
Spaeth GL, Monteiro de Barros DS, Gheith M, Siam GA, Nagarsheth M: How effectively does medical care achieve its purposes? Evaluation of peer-reviewed literature in ophthalmology related to wellness. Trans Am Ophthalmol Soc 2007;105:214–224.
12.
Mozes-Kor E: The Mengele twins and human experimentation: a personal account; in Annas GJ, Grodin MA (eds): Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation. Oxford, Oxford University Press, 1992, p 58.
13.
Yudkin JS, Lipska KJ, Montori VM: The idolatry of the surrogate. BMJ 2011;343:d7995.
14.
Harbin T: Waking Up Blind. Washington, Hillcrest Publishing Group, 2009.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.